메뉴 건너뛰기




Volumn 183, Issue 10, 2009, Pages 6217-6226

IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 27; PROSTAGLANDIN E2; VIMENTIN;

EID: 77952483010     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901272     Document Type: Article
Times cited : (66)

References (45)
  • 3
    • 0345358584 scopus 로고    scopus 로고
    • The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses
    • Trinchieri, G., S. Pflanz, and R. A. Kastelein. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19: 641-644.
    • (2003) Immunity , vol.19 , pp. 641-644
    • Trinchieri, G.1    Pflanz, S.2    Kastelein, R.A.3
  • 4
    • 21844444831 scopus 로고    scopus 로고
    • New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
    • Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531.
    • (2005) Nat. Rev. Immunol. , vol.5 , pp. 521-531
    • Hunter, C.A.1
  • 5
    • 3142709474 scopus 로고    scopus 로고
    • Understanding the pro- And anti-inflammatory properties of IL-27
    • Villarino, A. V., E. Huang, and C. A. Hunter. 2004. Understanding the pro- and anti-inflammatory properties of IL-27. J. Immunol. 173: 715-720.
    • (2004) J. Immunol. , vol.173 , pp. 715-720
    • Villarino, A.V.1    Huang, E.2    Hunter, C.A.3
  • 6
    • 0038326688 scopus 로고    scopus 로고
    • Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment
    • Takeda, A., S. Hamano, A. Yamanaka, T. Hanada, T. Ishibashi, T. W. Mak, A. Yoshimura, and H. Yoshida. 2003. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170: 4886-4890.
    • (2003) J. Immunol. , vol.170 , pp. 4886-4890
    • Takeda, A.1    Hamano, S.2    Yamanaka, A.3    Hanada, T.4    Ishibashi, T.5    Mak, T.W.6    Yoshimura, A.7    Yoshida, H.8
  • 12
    • 3042665905 scopus 로고    scopus 로고
    • Cyclooxygenase as a target in lung cancer
    • Brown, J. R., and R. N. DuBois. 2004. Cyclooxygenase as a target in lung cancer. Clin. Cancer Res. 10: 4266s-4269s.
    • (2004) Clin. Cancer Res. , vol.10
    • Brown, J.R.1    DuBois, R.N.2
  • 16
    • 12144291145 scopus 로고    scopus 로고
    • Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer
    • Põld, M., L. X. Zhu, S. Sharma, M. D. Burdick, Y. Lin, P. P. Lee, A. Põld, J. Luo, K. Krysan, M. Dohadwala, et al. 2004. Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer. Cancer Res. 64: 1853-1860.
    • (2004) Cancer Res. , vol.64 , pp. 1853-1860
    • Põld, M.1    Zhu, L.X.2    Sharma, S.3    Burdick, M.D.4    Lin, Y.5    Lee, P.P.6    Põld, A.7    Luo, J.8    Krysan, K.9    Dohadwala, M.10
  • 18
    • 0034026144 scopus 로고    scopus 로고
    • Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines
    • Hida, T., K. Kozaki, H. Muramatsu, A. Masuda, S. Shimizu, T. Mitsudomi, T. Sugiura, M. Ogawa, and T. Takahashi. 2000. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin. Cancer Res. 6: 2006-2011.
    • (2000) Clin. Cancer Res. , vol.6 , pp. 2006-2011
    • Hida, T.1    Kozaki, K.2    Muramatsu, H.3    Masuda, A.4    Shimizu, S.5    Mitsudomi, T.6    Sugiura, T.7    Ogawa, M.8    Takahashi, T.9
  • 22
    • 33244463813 scopus 로고    scopus 로고
    • Complex networks orchestrate epithelial-mesenchymal transitions
    • Thiery, J. P., and J. P. Sleeman. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7: 131-142.
    • (2006) Nat. Rev. Mol. Cell Biol. , vol.7 , pp. 131-142
    • Thiery, J.P.1    Sleeman, J.P.2
  • 23
    • 0037093230 scopus 로고    scopus 로고
    • High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer
    • Bremnes, R. M., R. Veve, E. Gabrielson, F. R. Hirsch, A. Baron, L. Bemis, R. M. Gemmill, H. A. Drabkin, and W. A. Franklin. 2002. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J. Clin. Oncol. 20: 2417-2428.
    • (2002) J. Clin. Oncol. , vol.20 , pp. 2417-2428
    • Bremnes, R.M.1    Veve, R.2    Gabrielson, E.3    Hirsch, F.R.4    Baron, A.5    Bemis, L.6    Gemmill, R.M.7    Drabkin, H.A.8    Franklin, W.A.9
  • 24
    • 0035105335 scopus 로고    scopus 로고
    • E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer
    • Liu, D., C. Huang, K. Kameyama, E. Hayashi, A. Yamauchi, S. Kobayashi, and H. Yokomise. 2001. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann. Thorac. Surg. 71: 949-954.
    • (2001) Ann. Thorac. Surg. , vol.71 , pp. 949-954
    • Liu, D.1    Huang, C.2    Kameyama, K.3    Hayashi, E.4    Yamauchi, A.5    Kobayashi, S.6    Yokomise, H.7
  • 25
    • 0344393065 scopus 로고    scopus 로고
    • The dynamic and motile properties of intermediate filaments
    • Helfand, B. T., L. Chang, and R. D. Goldman. 2003. The dynamic and motile properties of intermediate filaments. Annu. Rev. Cell Dev. Biol. 19: 445-467.
    • (2003) Annu. Rev. Cell Dev. Biol. , vol.19 , pp. 445-467
    • Helfand, B.T.1    Chang, L.2    Goldman, R.D.3
  • 26
    • 0035215429 scopus 로고    scopus 로고
    • Expression of E-cadherin and lymph node metastasis in resected non-small-cell lung cancer
    • Hirata, T., T. Fukuse, H. Naiki, and H. Wada. 2001. Expression of E-cadherin and lymph node metastasis in resected non-small-cell lung cancer. Clin. Lung Cancer 3: 134-140.
    • (2001) Clin. Lung Cancer , vol.3 , pp. 134-140
    • Hirata, T.1    Fukuse, T.2    Naiki, H.3    Wada, H.4
  • 27
    • 1042267263 scopus 로고    scopus 로고
    • Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
    • Cavallaro, U., and G. Christofori. 2004. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer. 4: 118-132.
    • (2004) Nat. Rev. Cancer. , vol.4 , pp. 118-132
    • Cavallaro, U.1    Christofori, G.2
  • 28
    • 33744925683 scopus 로고    scopus 로고
    • Cyclooxygenase-2-dependent regulation of E-cadherin: Prostaglandin E2 induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer
    • Dohadwala, M., S. C. Yang, J. Luo, S. Sharma, R. K. Batra, M. Huang, Y. Lin, L. Goodglick, K. Krysan, M. C. Fishbein, et al. 2006. Cyclooxygenase-2- dependent regulation of E-cadherin: prostaglandin E2 induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res. 66: 5338-5345.
    • (2006) Cancer Res. , vol.66 , pp. 5338-5345
    • Dohadwala, M.1    Yang, S.C.2    Luo, J.3    Sharma, S.4    Batra, R.K.5    Huang, M.6    Lin, Y.7    Goodglick, L.8    Krysan, K.9    Fishbein, M.C.10
  • 30
    • 0347320748 scopus 로고    scopus 로고
    • Notch1 can contribute to viral-induced transformation of primary human keratinocytes
    • Lathion, S., J. Schaper, P. Beard, and K. Raj. 2003. Notch1 can contribute to viral-induced transformation of primary human keratinocytes. Cancer Res. 63: 8687-8694.
    • (2003) Cancer Res. , vol.63 , pp. 8687-8694
    • Lathion, S.1    Schaper, J.2    Beard, P.3    Raj, K.4
  • 31
    • 43949093802 scopus 로고    scopus 로고
    • Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma
    • Ho, M. Y., G. H. Sun, S. J. Leu, S. M. Ka, S. J. Tang, and K. H. Sun. 2008. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma. Int. J. Cancer. 123: 123-133.
    • (2008) Int. J. Cancer. , vol.123 , pp. 123-133
    • Ho, M.Y.1    Sun, G.H.2    Leu, S.J.3    Ka, S.M.4    Tang, S.J.5    Sun, K.H.6
  • 32
    • 34848857434 scopus 로고    scopus 로고
    • Transforming growth factor-β and the immune response: Implications for anticancer therapy
    • Wrzesinski, S. H., Y. Y. Wan, and R. A. Flavell. 2007. Transforming growth factor-β and the immune response: implications for anticancer therapy. Clin. Cancer Res. 13: 5262-5270.
    • (2007) Clin. Cancer Res. , vol.13 , pp. 5262-5270
    • Wrzesinski, S.H.1    Wan, Y.Y.2    Flavell, R.A.3
  • 33
    • 0036143667 scopus 로고    scopus 로고
    • Novel approaches to the treatment of non-small cell lung cancer
    • Ferreira, C. G., C. Huisman, and G. Giaccone. 2002. Novel approaches to the treatment of non-small cell lung cancer. Crit. Rev. Oncol. Hematol. 41: 57-77.
    • (2002) Crit. Rev. Oncol. Hematol. , vol.41 , pp. 57-77
    • Ferreira, C.G.1    Huisman, C.2    Giaccone, G.3
  • 35
    • 29244449354 scopus 로고    scopus 로고
    • Prostaglandins and cancer
    • Wang, D., and R. N. Dubois. 2006. Prostaglandins and cancer. Gut 55: 115-122.
    • (2006) Gut , vol.55 , pp. 115-122
    • Wang, D.1    Dubois, R.N.2
  • 36
    • 40449118293 scopus 로고    scopus 로고
    • Immune modulation as a therapeutic strategy for non-small-cell lung cancer
    • Holt, G. E., and M. L. Disis. 2008. Immune modulation as a therapeutic strategy for non-small-cell lung cancer. Clin. Lung Cancer 9(Suppl. 1): S13-S19.
    • (2008) Clin. Lung Cancer , vol.9 , Issue.SUPPL. 1
    • Holt, G.E.1    Disis, M.L.2
  • 37
    • 33751568890 scopus 로고    scopus 로고
    • IL-27 induces Th1 differentiation via p38 MAPK/T-bet- And intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways
    • Owaki, T., M. Asakawa, F. Fukai, J. Mizuguchi, and T. Yoshimoto. 2006. IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. J. Immunol. 177: 7579-7587.
    • (2006) J. Immunol. , vol.177 , pp. 7579-7587
    • Owaki, T.1    Asakawa, M.2    Fukai, F.3    Mizuguchi, J.4    Yoshimoto, T.5
  • 38
  • 39
    • 34547187632 scopus 로고    scopus 로고
    • Several transcription factors regulate COX-2 gene expression in pancreatic β-cells
    • Zhang, X., J. Zhang, X. Yang, and X. Han. 2007. Several transcription factors regulate COX-2 gene expression in pancreatic β-cells. Mol. Biol. Rep. 34: 199-206.
    • (2007) Mol. Biol. Rep. , vol.34 , pp. 199-206
    • Zhang, X.1    Zhang, J.2    Yang, X.3    Han, X.4
  • 40
    • 2442674389 scopus 로고    scopus 로고
    • The role of Fas ligand and transforming growth factor β in tumor progression: Molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy
    • Kim, R., M. Emi, K. Tanabe, Y. Uchida, and T. Toge. 2004. The role of Fas ligand and transforming growth factor β in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy. Cancer 100: 2281-2291.
    • (2004) Cancer , vol.100 , pp. 2281-2291
    • Kim, R.1    Emi, M.2    Tanabe, K.3    Uchida, Y.4    Toge, T.5
  • 41
    • 33845524970 scopus 로고    scopus 로고
    • Transforming growth factor-β in cancer and metastasis
    • Jakowlew, S. B. 2006. Transforming growth factor-β in cancer and metastasis. Cancer Metastasis Rev. 25: 435-457.
    • (2006) Cancer Metastasis Rev. , vol.25 , pp. 435-457
    • Jakowlew, S.B.1
  • 42
    • 34447345406 scopus 로고    scopus 로고
    • The biology and therapeutic potential of interleukin 27
    • Batten, M., and N. Ghilardi. 2007. The biology and therapeutic potential of interleukin 27. J. Mol. Med. 85: 661-672.
    • (2007) J. Mol. Med. , vol.85 , pp. 661-672
    • Batten, M.1    Ghilardi, N.2
  • 45
    • 33745685864 scopus 로고    scopus 로고
    • Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma
    • Oniki, S., H. Nagai, T. Horikawa, J. Furukawa, M. L. Belladonna, T. Yoshimoto, I. Hara, and C. Nishigori. 2006. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. Cancer Res. 66: 6395-6404.
    • (2006) Cancer Res. , vol.66 , pp. 6395-6404
    • Oniki, S.1    Nagai, H.2    Horikawa, T.3    Furukawa, J.4    Belladonna, M.L.5    Yoshimoto, T.6    Hara, I.7    Nishigori, C.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.